OPNT - Opiant Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts3333
Avg. Estimate-0.55-0.460.4-0.95
Low Estimate-0.72-0.74-1.3-3.55
High Estimate-0.32-0.272.054.07
Year Ago EPS-0.52-0.32-7.10.4
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts3333
Avg. Estimate4.01M4.61M28.23M27.58M
Low Estimate2.9M4.1M18.6M19.7M
High Estimate4.92M5.32M34.78M40M
Year Ago Sales3.15MN/A13.98M28.23M
Sales Growth (year/est)27.30%N/A101.90%-2.30%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-1.07-0.4-0.13-0.79
EPS Actual-0.52-0.32-0.37-0.44
Difference0.550.08-0.240.35
Surprise %51.40%20.00%-184.60%44.30%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.55-0.460.4-0.95
7 Days Ago-0.55-0.460.4-0.95
30 Days Ago-0.62-0.38-0.370.74
60 Days Ago-0.62-0.38-0.370.74
90 Days Ago-0.74-0.772.51-0.4
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/A1N/A
Up Last 30 DaysN/AN/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days11N/A1
Growth EstimatesOPNTIndustrySectorS&P 500
Current Qtr.-5.80%N/AN/A0.02
Next Qtr.-43.80%N/AN/A0.04
Current Year105.60%N/AN/A0.05
Next Year-337.50%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A